These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG. Mol Cell Biol; 1999 Dec; 19(12):8383-92. PubMed ID: 10567563 [Abstract] [Full Text] [Related]
3. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. He B, Wilson EM. Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084 [Abstract] [Full Text] [Related]
4. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Dubbink HJ, Hersmus R, Pike AC, Molier M, Brinkmann AO, Jenster G, Trapman J. Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595 [Abstract] [Full Text] [Related]
5. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Bai S, He B, Wilson EM. Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378 [Abstract] [Full Text] [Related]
6. Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1. Sheppard HM, Harries JC, Hussain S, Bevan C, Heery DM. Mol Cell Biol; 2001 Jan; 21(1):39-50. PubMed ID: 11113179 [Abstract] [Full Text] [Related]
7. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B. Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017 [Abstract] [Full Text] [Related]
8. Expression and function of androgen receptor coactivators in prostate cancer. Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobisch A. J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989 [Abstract] [Full Text] [Related]
9. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells. Rivera OJ, Song CS, Centonze VE, Lechleiter JD, Chatterjee B, Roy AK. Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612 [Abstract] [Full Text] [Related]
10. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor. Dotzlaw H, Papaioannou M, Moehren U, Claessens F, Baniahmad A. Mol Cell Endocrinol; 2003 Dec 31; 213(1):79-85. PubMed ID: 15062576 [Abstract] [Full Text] [Related]
11. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region. Wang Q, Lu J, Yong EL. J Biol Chem; 2001 Mar 09; 276(10):7493-9. PubMed ID: 11102454 [Abstract] [Full Text] [Related]
12. A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP. Matsuda S, Harries JC, Viskaduraki M, Troke PJ, Kindle KB, Ryan C, Heery DM. J Biol Chem; 2004 Apr 02; 279(14):14055-64. PubMed ID: 14722092 [Abstract] [Full Text] [Related]
13. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. Ikonen T, Palvimo JJ, Jänne OA. J Biol Chem; 1997 Nov 21; 272(47):29821-8. PubMed ID: 9368054 [Abstract] [Full Text] [Related]
14. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B. Mol Cell Biol; 1999 Sep 21; 19(9):6085-97. PubMed ID: 10454556 [Abstract] [Full Text] [Related]
15. Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control. Christiaens V, Bevan CL, Callewaert L, Haelens A, Verrijdt G, Rombauts W, Claessens F. J Biol Chem; 2002 Dec 20; 277(51):49230-7. PubMed ID: 12370175 [Abstract] [Full Text] [Related]
16. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. He B, Kemppainen JA, Wilson EM. J Biol Chem; 2000 Jul 28; 275(30):22986-94. PubMed ID: 10816582 [Abstract] [Full Text] [Related]
17. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity. He B, Gampe RT, Hnat AT, Faggart JL, Minges JT, French FS, Wilson EM. J Biol Chem; 2006 Mar 10; 281(10):6648-63. PubMed ID: 16365032 [Abstract] [Full Text] [Related]
19. Expression of androgen receptor coregulators in prostate cancer. Linja MJ, Porkka KP, Kang Z, Savinainen KJ, Jänne OA, Tammela TL, Vessella RL, Palvimo JJ, Visakorpi T. Clin Cancer Res; 2004 Feb 01; 10(3):1032-40. PubMed ID: 14871982 [Abstract] [Full Text] [Related]
20. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. Kang HY, Yeh S, Fujimoto N, Chang C. J Biol Chem; 1999 Mar 26; 274(13):8570-6. PubMed ID: 10085091 [Abstract] [Full Text] [Related] Page: [Next] [New Search]